title: Mechanisms of dexamethasone-mediated inhibition of Toll-like receptor signaling induced by Neisseria meningitidis and Streptococcus pneumoniae.
abstract: Excessive inflammation contributes to the pathogenesis of bacterial meningitis, which remains a serious disease despite treatment with antibiotics. Therefore, anti-inflammatory drugs have important therapeutic potential, and clinical trials have revealed that early treatment with dexamethasone significantly reduces mortality and morbidity from bacterial meningitis. Here we investigate the molecular mechanisms behind the inhibitory effect of dexamethasone upon the inflammatory responses evoked by Neisseria meningitidis and Streptococcus pneumoniae, two of the major causes of bacterial meningitis. The inflammatory cytokine response was dependent on Toll-like receptor signaling and was strongly inhibited by dexamethasone. Activation of the NF-kappaB pathway was targeted at several levels, including inhibition of IkappaB phosphorylation and NF-kappaB DNA-binding activity as well as upregulation of IkappaB alpha synthesis. Our data also revealed that the timing of steroid treatment relative to infection was important for achieving strong inhibition, particularly in response to S. pneumoniae. Altogether, we describe important targets of dexamethasone in the inflammatory responses evoked by N. meningitidis and S. pneumoniae, which may contribute to our understanding of the clinical effect and the importance of timing with respect to corticosteroid treatment during bacterial meningitis.
authors.affiliation: Department of Infectious Diseases, Skejby Hospital, Brendstrupgaardsvej, DK-8200 Aarhus N, Denmark. trine.mogensen@dadlnet.dk
authors.forename: Trine H
authors.initials: TH
authors.lastname: Mogensen
authors.forename: Randi S
authors.initials: RS
authors.lastname: Berg
authors.forename: Søren R
authors.initials: SR
authors.lastname: Paludan
authors.forename: Lars
authors.initials: L
authors.lastname: Østergaard
mesh_terms: D000328:Adult; D000818:Animals; D002478:Cells, Cultured; D003907:Dexamethasone / Q000494:pharmacology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology; D008264:Macrophages / Q000378:metabolism / Q000382:microbiology; D051379:Mice; D009345:Neisseria meningitidis / Q000378:metabolism*; D009504:Neutrophils / Q000187:drug effects* / Q000378:metabolism / Q000382:microbiology; D012333:RNA, Messenger / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects*; D013296:Streptococcus pneumoniae / Q000378:metabolism*; D051193:Toll-Like Receptors / Q000378:metabolism*
chemical_list: D007166:Immunosuppressive Agents; D012333:RNA, Messenger; D051193:Toll-Like Receptors; D003907:Dexamethasone